1700108M19Rik Activators
Chemical activators of leucine rich repeat containing 72 can influence the protein's function through various intracellular signaling pathways. Forskolin, for instance, elevates cAMP levels inside cells by activating adenylate cyclase. The increase in cAMP activates protein kinase A (PKA), which can then phosphorylate proteins that are part of the signaling pathways involving leucine rich repeat containing 72, leading to its functional activation. Similarly, dibutyryl cAMP, a cAMP analog, directly activates PKA, promoting the phosphorylation and consequent activation of leucine rich repeat containing 72. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which also phosphorylates serine and threonine residues on proteins that can include leucine rich repeat containing 72, thereby contributing to its activation.
On the other hand, ionomycin acts as a calcium ionophore that increases intracellular calcium levels. Elevated calcium levels can activate kinases such as calcium/calmodulin-dependent protein kinases (CaMK), which may then activate leucine rich repeat containing 72. Calmodulin, when complexed with calcium, activates various kinases and phosphatases, potentially leading to the phosphorylation or dephosphorylation of leucine rich repeat containing 72, influencing its activity. Epidermal Growth Factor (EGF) stimulates its receptor, triggering the MAPK/ERK pathway, which can result in the activation of leucine rich repeat containing 72 through phosphorylation events. Bradykinin initiates a cascade via its receptor that releases calcium and activates PKC, which may phosphorylate leucine rich repeat containing 72. Thapsigargin inhibits the SERCA pump, causing calcium accumulation in the cytosol and potentially activating leucine rich repeat containing 72 through downstream kinase pathways. Similarly, okadaic acid, by inhibiting phosphatases, promotes protein phosphorylation within signaling pathways encompassing leucine rich repeat containing 72. Anisomycin, although a protein synthesis inhibitor, activates stress-activated protein kinases like JNK that can lead to the activation of leucine rich repeat containing 72. Lastly, Cyclosporin A disrupts calcineurin activity, altering phosphorylation states of proteins, which can include leucine rich repeat containing 72, thereby influencing its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Calcium signaling is crucial in various cellular processes and can activate kinases such as calcium/calmodulin-dependent protein kinases (CaMK), which may activate leucine rich repeat containing 72 as part of downstream signaling cascades. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on many cellular proteins. PKC-mediated phosphorylation can lead to the functional activation of proteins within the same pathway as leucine rich repeat containing 72, resulting in its activation. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin, when bound to calcium, becomes an active complex that can interact with and activate various kinases and phosphatases. These enzymes can then phosphorylate or dephosphorylate leucine rich repeat containing 72 or its associated proteins, leading to leucine rich repeat containing 72 activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to phosphorylation events that activate leucine rich repeat containing 72 through downstream signaling effects. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin binds to its G-protein-coupled receptor, initiating a cascade of intracellular events including the release of calcium from intracellular stores and activation of PKC. These events can contribute to the activation of leucine rich repeat containing 72 through phosphorylation or other post-translational modifications. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. The rise in calcium can activate downstream kinases such as CaMK, which may result in the activation of leucine rich repeat containing 72. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation of cellular proteins. This inhibition can lead to the hyperactivation of proteins within signaling pathways that include leucine rich repeat containing 72, resulting in its functional activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases (SAPKs) like JNK. Activation of these kinases can result in the activation of components in signaling pathways that involve leucine rich repeat containing 72, leading to its functional activation. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A binds to the cyclophilins and inhibits calcineurin, a phosphatase involved in the activation of T-cells. Inhibition of calcineurin can lead to altered phosphorylation states of proteins in pathways where leucine rich repeat containing 72 is involved, leading to its activation. | ||||||